November 5, 2020
In oncology, many manufacturers go into niche indications, where there are very specific tumors, and then they opt for..
October 22, 2020
In this two-part blog series, we interview Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel..
October 20, 2020
In this interview with Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), we talk to him about his..
October 19, 2020
COVID-19 has created extreme uncertainties -- a dearth of historical information combined with the need for safety,..
October 14, 2020
A credible evidence base is needed to support and document the economic value of new technologies and therapeutic..
September 22, 2020
Research Scientists, Thomas Wilke and Sabrina Mueller recently published a manuscript on “Diabetes-Related..
August 26, 2020
As Chief Scientific Officer, Dr. Yannis Jemiai plays a pivotal role in maintaining Cytel’s well-established reputation..
August 5, 2020
Cytel is conducting two pilot projects on head-to-head comparisons using real world data. These projects in oncology..
July 23, 2020
Just as there are numerous adaptations that fall within the umbrella of adaptive designs, there are several different..